Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis
The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severi...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Bianca de Almeida-Pititto, Patr ícia M. Dualib, Lenita Zajdenverg, Joana Rodrigues Dantas, Filipe Dias de Souza, Melanie Rodacki and Marcello Casaccia Bertoluci Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | COVID-19 | Diabetes | Endocrinology | Heart | Hypertension | Metabolic Syndrome | Study